$2.81
0.093.31%
At close: -
$2.99
0.186.41%
After Hours: 6:33 PM EDT
Comments
Loading...
Inhibikase Therapeutics (NASDAQ:IKT) Stock, Earnings Estimates, EPS, And Revenue
Inhibikase Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 26
EPS Estimate
$-0.100
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Inhibikase Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Inhibikase Therapeutics (IKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.65 | $-0.67 | 2.99 % |
| Q2 | 2024-08-14 | $-0.66 | $-0.67 | 1.49 % |
| Q1 | 2024-05-15 | $-0.73 | $-0.79 | 7.59 % |
| Q4 | 2024-03-27 | $-0.64 | $-0.85 | 24.7 % |
Inhibikase Therapeutics (IKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2022-11-14 | $7.29K | $200.00K | -96.4 % |
| Q2 | 2022-08-12 | $6.55K | $300.00K | -97.8 % |
| Q1 | 2022-05-16 | $46.03K | $300.00K | -84.7 % |
| Q4 | 2022-03-31 | $1.94M | $300.00K | 548.0 % |
FAQ
When is Inhibikase Therapeutics (NASDAQ:IKT) reporting earnings?
Inhibikase Therapeutics (IKT) is scheduled to report earnings on March 26, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Inhibikase Therapeutics (NASDAQ:IKT)?
The Actual EPS was $-0.65, which beat the estimate of $-0.67.
What were Inhibikase Therapeutics’s (NASDAQ:IKT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.